Blood glucose equipment control method, system and device, storage medium and program

A technology for equipment control and blood sugar, which is applied in the field of biomedical engineering, can solve the problems of insufficient efficiency, convenience, and little difference in basic functions, etc., and achieve the effects of effective control of diabetes, efficient treatment of high blood sugar, and improvement of quality of life

Pending Publication Date: 2020-09-11
QUJING NORMAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the blood glucose meter in the market still has a tendency of homogeneity, the difference in basi...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Blood glucose equipment control method, system and device, storage medium and program
  • Blood glucose equipment control method, system and device, storage medium and program
  • Blood glucose equipment control method, system and device, storage medium and program

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] A design method for intelligent real-time drug administration to control hyperglycemia, including the following four steps:

[0055] 1) Enter the transmission chip and connect the device;

[0056] 2) In the blood glucose reference interface of the transmission chip, a normal blood glucose concentration range (3.1-6.9mmol / L) is set, and any blood glucose value within this range is considered normal;

[0057] 3) Receive the data from the biosensor at all times and compare it with the blood glucose reference (standard blood glucose concentration) of the transmission chip. When the client shows that the blood glucose level is higher than 6.9mmol / L, the transmission chip will issue a command to the biosensor, and the biosensor will control the release of hypoglycemic drugs (such as insulin, metformin, etc.);

[0058] 4) The biosensor releases hypoglycemic drugs (such as insulin, metformin, etc.) to continue to regulate blood sugar, and the transmission chip receives data fr...

Embodiment 2

[0060] 1) The biosensor is in direct contact with the skin to detect the concentration of glucose in the surface capillaries connected to the skin;

[0061] 2) The detected data will be displayed on the biosensor display screen in the form of numbers, and displayed on the transmission chip in the form of graphs;

[0062] 3) At the same time, the data detected at this time is transmitted to the transmission chip system through the chip;

[0063] 4) The transmission chip system compares the detected data with the normal blood sugar concentration (3.1-6.9mmol / L) for judgment;

[0064] 5) If the client shows that the blood glucose concentration is within the normal range of human blood glucose (3.1-6.9mmol / L), the transmission chip will not issue a drug administration command to the biosensor, and the biosensor will not respond;

Embodiment 3

[0066] A design method for intelligent real-time drug administration to control hyperglycemia, including the following four steps:

[0067] 1) Enter the transmission chip and connect the device;

[0068] 2) In the blood glucose reference interface of the transmission chip, a normal blood glucose concentration range (3.1-6.9mmol / L) is set, and any blood glucose value within this range is considered normal;

[0069] 3) Receive the data from the biosensor at all times and compare it with the blood glucose reference (3.1-6.9mmol / L) of the transmission chip. If the blood glucose value is higher than 6.9mmol / L, the transmission chip will issue a command to the biosensor, and the biosensor will control the release of hypoglycemic drugs (such as insulin, metformin, etc.)

[0070] 4) The biosensor releases hypoglycemic drugs (such as insulin, metformin, etc.) to continue to regulate blood sugar, and the transmission chip receives data from the biosensor again. At this time, the blood ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of biomedical engineering, and discloses a blood glucose equipment control method, system and device, a storage medium and a program. According to the method, intelligent real-time administration hyperglycemia control equipment is connected; a normal blood glucose concentration range is set to be 3.1 mmol/L to 6.9 mmol/L; a client constantly receives equipment detection data and compares the equipment detection data with a standard blood glucose concentration stored in the client for reference; if the blood glucose concentration exceeds the blood glucose concentration range, a command is sent to control the release of a hypoglycemic agent, and otherwise, no response is made; if the equipment releases the hypoglycemic agent to continuously adjustthe blood sugar, related detection data are received again, if the blood sugar value is normal, a command is sent out, and the intelligent real-time administration hyperglycemia control equipment controls to stop the release of the hypoglycemic agent. According to the invention, through real-time on-line monitoring, the dosage can be intelligently, scientifically and reasonably controlled, so that the dosage of a patient can be controlled at a reasonable level according to individual differences; and timely on-line feedback is realized, so that tedious manual administration is avoided, and the purpose of effectively controlling diabetes mellitus is achieved.

Description

technical field [0001] The invention belongs to the technical field of biomedical engineering, and in particular relates to a control method, system, device, storage medium and program for blood sugar equipment. Background technique [0002] Hyperglycemia is the most common chronic disease and the main risk factor for cardiovascular and cerebrovascular diseases. It can cause cerebral hemorrhage and cerebral blood vessel rupture. With the continuous growth of my country's aging population, hyperglycemia has become the fastest-growing disease among all chronic diseases in my country. Among hyperglycemic people, patients almost always control blood sugar by injecting insulin, but there are many risk factors in this way. When injecting, if the disinfection is not in place or the amount of insulin is not properly controlled, it will lead to many serious consequences, including eyes, kidneys, cardiovascular and cerebrovascular diseases, hyperglycemia, skin itching, etc., and once...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G16H20/17G16H50/20
CPCG16H20/17G16H50/20
Inventor 王建玲杨海征何琼
Owner QUJING NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap